{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Reno",
      "state": "NV",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89501",
      "recalling_firm": "Esupplementsales, LLC",
      "address_1": "1670 Saturno Heights Dr",
      "address_2": "N/A",
      "postal_code": "89523-3217",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide in the USA via Amazon at www.amazon.com",
      "recall_number": "D-0561-2022",
      "product_description": "HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59",
      "product_quantity": "500 cartons",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.",
      "recall_initiation_date": "20220128",
      "center_classification_date": "20220215",
      "termination_date": "20220817",
      "report_date": "20220216",
      "code_info": "Lot: 2107, Exp July 2024"
    }
  ]
}